Related Experiment Videos
Multiple Grb2-protein complexes in human cancer cells
1Department of Biochemistry, Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC 20007. USA.
Abstract:
Grb2 is an SH2/SH3 domain-containing adaptor protein that links receptor tyrosine kinases to the ras signaling pathway. The Grb2-SH2 domain binds phosphotyrosine sequences on activated tyrosine kinases, and one target of the SH3 domains is the ras-nucleotide-exchange factor Sos1. We have examined Grb2-protein interactions in human cancer cells that over-express the receptor tyrosine kinase erbB2. Our results show that the 2 Grb2-SH3 domains complex with Sos1, dynamin and at least 4 other proteins (p228, p140, p55, p28) in these cells. The 2 Grb2-SH3 domains bind these proteins differently, with the N-terminal SH3 domain interacting preferentially with p228, Sos1, p140 and dynamin. The C-terminal SH3 domain has higher affinity toward p28. The Grb2-SH3 domain interactions appear to be similar in erbB2 over-expressing breast, ovarian and lung cancer cells. Also, the major tyrosine-phosphorylated proteins that associate with Grb2 in erbB2 over-expressing cancer cells appear to be erbB2 and Shc. The multiple Grb2-SH3 domain interactions in these cells may mediate novel cellular functions.
Insights
Grb2 adaptor protein interactions were studied in cancer cells over-expressing erbB2. The Grb2 protein
Area of Science:
- Molecular Biology
- Cell Signaling
- Cancer Research
Background:
- Grb2 (Growth factor receptor-bound protein 2) is an adaptor protein crucial for linking receptor tyrosine kinases (RTKs) to the Ras signaling pathway.
- Its SH2 domain binds activated RTKs, while its SH3 domains target proteins like Sos1 (Son of Sevenless homolog 1), a guanine nucleotide exchange factor.
Purpose of the Study:
- To investigate Grb2-protein interactions in human cancer cells with over-expressed erbB2 (Erb-b2 receptor tyrosine kinase 2).
- To characterize the differential binding of Grb2's SH2 and SH3 domains to various cellular proteins.
Main Methods:
- Analysis of Grb2-protein complexes using human cancer cell lines over-expressing erbB2.
- Identification and characterization of proteins interacting with Grb2's N-terminal and C-terminal SH3 domains.
Main Results:
- The two Grb2 SH3 domains complex with Sos1, dynamin, and at least four other proteins (p228, p140, p55, p28) in erbB2-overexpressing cells.
- The N-terminal SH3 domain preferentially binds p228, Sos1, p140, and dynamin, while the C-terminal SH3 domain shows higher affinity for p28.
- These interaction patterns are consistent across erbB2-overexpressing breast, ovarian, and lung cancer cells.
- ErbB2 and Shc are the primary tyrosine-phosphorylated proteins associating with Grb2 in these cells.
Conclusions:
- Grb2 exhibits distinct protein interaction profiles mediated by its N-terminal and C-terminal SH3 domains in erbB2-overexpressing cancer cells.
- These complex interactions involving Grb2 may facilitate novel cellular functions within the context of RTK signaling in cancer.
- Understanding these interactions provides insights into the role of Grb2 in oncogenesis driven by erbB2.